Author

Shiraj Sen

Observed institution: The University of Texas Southwestern Medical Center

OpenAlex ID: A5068668795

Initial results from a first-in-human phase 1 study of SNS-101 (pH-selective anti-VISTA antibody) alone or in combination with cemiplimab in patients with advanced solid tumors.

2024 · Shiraj Sen, Justin A Call, et al. · Journal of Clinical Oncology · 10

Impact of immune checkpoint inhibitor dose on toxicity, response rate, and survival: A pooled analysis of dose escalation phase 1 trials.

2018 · Shiraj Sen, Kenneth R. Hess, et al. · Journal of Clinical Oncology · 10

NAPISTAR 1-01: Results of phase 1 dose escalation of monotherapy with TUB-040, a novel NaPi2b-targeting exatecan ADC, in patients (pts) with platinum-resistant ovarian cancer (PROC).

2026 · Toon Van Gorp, Jalid Sehouli, et al. · Journal of Clinical Oncology · 3

PDF

TUB-030, a novel ADC targeting 5T4: A phase I/IIa multi-center, first-in-human clinical trial (5-STAR 1-01) in patients with advanced solid tumors.

2025 · Shiraj Sen, Sheena Sahota, et al. · Journal of Clinical Oncology · 3

Characterization of KEAP1-NRF2 genomic alterations across diverse tumor types: Co-occurring alterations, survival outcomes, and implications for targeting cancer metabolism.

2018 · Shiraj Sen, Kenneth R. Hess, et al. · Journal of Clinical Oncology · 2

NAPISTAR 1-01 - An International Phase I/II Trial Of The Novel NaPi2b Targeting ADC TUB-040 In Platinum-Resistant Ovarian Cancer (PROC) And Relapsed/Refractory Non Small Cell Lung Cancer (NSCLC)

2025 · Toon Van Gorp, Shiraj Sen, et al. · International Journal of Gynecological Cancer · 1

PDF

1464 Phase 1 results of OR502, an antibody against leukocyte immunoglobulin-like receptor B2 (LILRB2), in patients with advanced cancers

2024 · Shiraj Sen, Andrae L Vandross, et al. · 1

Persistent Intracardiac Thrombus: Could it be Cancer?

2015 · Shiraj Sen, Harris V. Naina, et al. · Journal of General Internal Medicine · 1

PDF

PRTH-101: An investigational treatment for thoracic solid tumors targeting discoidin domain receptor (DDR1) and the tumor microenvironment (TME).

2026 · Funda Meric-Bernstam, So Yeon Kim, et al. · Journal of Clinical Oncology

A phase 1, first-in-human study of DS5361, a small-molecule, nonsense-mediated mRNA decay (NMD) inhibitor in patients with advanced/metastatic solid tumors (parts 1 and 2).

2026 · Shiraj Sen, Benedito A. Carneiro, et al. · Journal of Clinical Oncology

Phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of TGW101 in patients with advanced solid tumors.

2026 · Anthony W. Tolcher, Alexander I. Spira, et al. · Journal of Clinical Oncology

PDF

Early results from the first-in-human phase 1 study of WEE1 inhibitor APR-1051 in patients with advanced solid tumors (ACESOT-1051).

2026 · Shiraj Sen, David Sommerhalder, et al. · Journal of Clinical Oncology

184 Tumor biomarker analysis of anti-CD39 monoclonal antibody AB598 in a first-in-human phase I trial in patients with advanced solid tumors

2025 · Angelo Kaplan, Haben Ghermazien, et al. · Regular and Young Investigator Award Abstracts

PDF

Abstract A113: Micvotabart pelidotin, a non-cellular targeting ADC, remodels the tumor microenvironment in tumors from participants in a phase 1 dose escalation study

2025 · Sara Lewandowski, Justin Trickett, et al. · Molecular Cancer Therapeutics

Abstract LB299: Clinical pharmacokinetics and peripheral receptor occupancy of OR502, best-in-class antibody against leukocyte immunoglobulin-like receptor B2 (LILRB2), alone and in combination with cemiplimab

2025 · Andrae Vandross, David Sommerhalder, et al. · Cancer Research

Predictors of Outcome in HIV-associated Primary Effusion Lymphoma

2015 · Shiraj Sen, Arjun Gupta, et al. · Clinical Lymphoma Myeloma & Leukemia

Body mass index and mortality in patients with pancreatic cancer: A systematic review and meta-analysis of observational studies.

2015 · Arjun Gupta, Kaustav Majumder, et al. · Journal of Clinical Oncology

Everything Points to Myeloma

2015 · Arjun Gupta, Shiraj Sen, et al. · Journal of General Internal Medicine

PDF

Works count: 18

Citation count: 31

H-index: 3

I10-index: 2